Literature DB >> 19904010

Chronic beta-adrenergic activation-induced left ventricular systolic dysfunction is associated with systemic release of TNF-alpha and IL-1-beta in rats.

Santosh Kumar1, Sandeep Seth, Amardeep Jaiswal, Rajesh Enjamoori, Amit K Dinda, Ruma Ray, Subir K Maulik.   

Abstract

The relationship between systemic cytokine release and chronic beta-adrenergic activation-induced left ventricular dysfunction (LVSD) has not been widely reported in the literature. In the present study,we examined changes in the serum levels of inflammatory cytokines (IL-1-beta, IL-6 and TNF-alpha) following chronic beta-adrenergic activation-induced LVSD. Male Wistar rats were administered isoproterenol (ISO, 5 mg/kg, sc, once daily) for 4 weeks (ISO 4) or 12 weeks (ISO 12). Echocardiography was done and serum levels of IL-1-beta, IL-6 and TNF-alpha were estimated at the end of each protocol. In the ISO 4 group, there was a significant increase in relative wall thickness (p < 0.01) and heart weight: body weight ratio (p < 0.001) without any significant changes in fractional shortening (FS) or serum cytokine levels. However, in the ISO 12 group, there was a 32% decrease in FS along with increased serum levels of IL-1-beta and TNF-alpha. The present findings indicate that LVSD induced by chronic beta-adrenergic activation in rats is accompanied by increased serum cytokine levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19904010     DOI: 10.1016/s1734-1140(09)70143-4

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  6 in total

1.  Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt.

Authors:  H Aceros; G Farah; L Cobos-Puc; A M Stabile; N Noiseux; S Mukaddam-Daher
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

2.  Telomere length and adrenergic-induced left ventricular dilatation and systolic chamber dysfunction in rats.

Authors:  Andrew R Raymond; Bryan Hodson; Angela J Woodiwiss; Gavin R Norton; Richard L Brooksbank
Journal:  Eur J Appl Physiol       Date:  2013-09-06       Impact factor: 3.078

3.  β-Adrenoreceptor Agonist Isoproterenol Alters Oxidative Status, Inflammatory Signaling, Injury Markers and Apoptotic Cell Death in Myocardium of Rats.

Authors:  Santosh K Shukla; Suman B Sharma; Usha R Singh
Journal:  Indian J Clin Biochem       Date:  2014-01-23

4.  Effect of U50,488H, a κ-opioid receptor agonist on myocardial α-and β-myosin heavy chain expression and oxidative stress associated with isoproterenol-induced cardiac hypertrophy in rat.

Authors:  Amardeep Jaiswal; Santosh Kumar; Sandeep Seth; Amit Kumar Dinda; Subir Kumar Maulik
Journal:  Mol Cell Biochem       Date:  2010-08-21       Impact factor: 3.396

5.  PEG-coated gold nanoparticles attenuate β-adrenergic receptor-mediated cardiac hypertrophy.

Authors:  Yuhui Qiao; Baoling Zhu; Aiju Tian; Zijian Li
Journal:  Int J Nanomedicine       Date:  2017-07-03

6.  Qi-Li-Qiang-Xin Alleviates Isoproterenol-Induced Myocardial Injury by Inhibiting Excessive Autophagy via Activating AKT/mTOR Pathway.

Authors:  Cailian Fan; Xiyang Tang; Mengnan Ye; Guonian Zhu; Yi Dai; Zhihong Yao; Xinsheng Yao
Journal:  Front Pharmacol       Date:  2019-11-12       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.